CA
CASI Pharmaceuticals, Inc.
CASIF · OTC
$0.13 -4.59% (-$0.01)
1M +0.00%
Market Cap $2.65M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.13x
EV/EBITDA N/A
P/B N/A
Growth
9 /100
Declining Book val. growth 72.02%
Rev. growth 1.84%
FCF growth N/A
Profitability
22 /100
Weak Net margin 218.55%
Op. margin 190.98%
FCF margin 0.00%
Quality
74 /100
Excellent ROA 208.70%
Asset turnover 0.95x
ROIC 759.62%
Debt
0 /100
High Int. coverage -100.15x
Current ratio 0.15x
Net debt/EBITDA N/A
Stability
35 /100
Moderate Rev. volatility 35.61%
EPS volatility 31.04%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o CASIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David A. Cory
Employees
214
Headquarters
Beijing
Nadchodzące wydarzenia
25 WRZ
Earnings
Upcoming earnings report
13 LIS
Earnings
Upcoming earnings report